Brajesh Ratre

Brajesh Ratre

Auto-generated profile, based on publicly available information

Brajesh Ratre

Department of Onco-Anaesthesia and Palliative Medicine, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital (DR BRAIRCH), All India Institute of Medical Sciences (AIIMS), New Delhi, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Closed access
KPKhushboo Pandey
Khushboo Pandey
SVSaurabh Vig
Saurabh Vig
BRBrajesh Ratre
Brajesh Ratre
NGNishkarsh Gupta
Nishkarsh Gupta

20 January 2026 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
SSSurabhi Sandill
Surabhi Sandill
SMSeema Mishra
Seema Mishra
RGRakesh Garg
Rakesh Garg
NGNishkarsh Gupta
Nishkarsh Gupta
SBSachidanand Jee Bharti
Sachidanand Jee Bharti
SBSushma Bhatnagar
Sushma Bhatnagar
In India, where cancer incidence is rising, and healthcare infrastructure in tertiary care centers is strained, the outcomes of cancer patients requiring intensive care unit (ICU) care remain poorly understood. We aim to describe demographic, clinical, and survival data and to identify factors associated with mortality in non-elective medical admissions of critically ill cancer patients to ICU in a tertiary care hospital. Retrospective observational study of non-elective medical admissions of critically ill adult cancer patients to the ICU with a diagnosis of solid organ or hematological malignancies between 1st January 2018 and 31st December 2022. Data regarding patient and neoplasm characteristics, ICU admission features, and outcomes were collected from medical records and ICU charts. A total of 204 non-elective medical admissions of critically ill cancer patients to the ICU were analyzed. Hematological malignancies were documented in 53.9% patients. The main causes of admission to the ICU were febrile neutropenia (34.3%), respiratory failure (31.8%), sepsis (9.8%), and shock (7.8%). The mean length of ICU stay was 5.62 ± 5.67 days. Intensive care unit mortality was 52.94%. The most common cause of mortality was septic shock (53.7%). The need for invasive mechanical ventilation (IMV) [adjusted odds ratio (OR) 0.113; 95% confidence interval (CI) 15.98 (4.22–60.56), p < 0.001], use of vasopressors (adjusted OR 12.59; 95% CI: 3.45–45.94, p < 0.001), need for dialysis (adjusted OR 17.99; 95% CI: 1.97–164.45, p = 0.01), and tracheostomy (adjusted OR 0.15; 95% CI: 0.03–0.7, p = 0.016), were independent risk factors associated with higher ICU mortality. An increasing number of cancer patients require intensive care, and our study suggests that many of these patients have a reasonable chance of surviving their ICU stay. The in-ICU mortality of 52.94% was observed at our tertiary care center in India. Independent predictors of mortality included age, type of malignancy, treatment intent, need for early IMV, vasopressors, and dialysis in the ICU. Sandill S, Mishra S, Garg R, Gupta N, Bharti SJ, Kumar V, et al. Outcomes of Cancer Patients Requiring Non-elective Medical Admission to the Intensive Care Unit of a Tertiary Care Center in India: A 5-year Retrospective Study. Indian J Crit Care Med 2026;30(1):13–18.

2 February 2026 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
HVHimanshu Varshney
Himanshu Varshney
PMPrateek Maurya
Prateek Maurya
NGNishkarsh Gupta
Nishkarsh Gupta
ABAtul Batra
Atul Batra
AGAjay Gogia
Ajay Gogia
SBSushma Bhatnagar
Sushma Bhatnagar